IDEXX LABORATORIES INC /DE Income Tax Expense
IDEXX LABORATORIES INC /DE (IDXX) reported Income Tax Expense of $78.81 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-04
- IDEXX LABORATORIES INC /DE income tax expense (benefit) for the quarter ending 2026-06-30 was $78.81M, a 15.28% increase year-over-year.
- IDEXX LABORATORIES INC /DE income tax expense (benefit) for the quarter ending 2026-03-31 was $77.00M, a 14.23% increase year-over-year.
- IDEXX LABORATORIES INC /DE income tax expense (benefit) for the quarter ending 2025-12-31 was $58.79M, a 46.12% increase year-over-year.
- IDEXX LABORATORIES INC /DE income tax expense (benefit) for the quarter ending 2025-09-30 was $70.16M, a 6.20% increase year-over-year.
- IDEXX LABORATORIES INC /DE income tax expense (benefit) for fiscal 2025 was $264.73M, a 19.26% increase from fiscal 2024.
- IDEXX LABORATORIES INC /DE income tax expense (benefit) for fiscal 2024 was $221.96M, a 2.70% increase from fiscal 2023.
- IDEXX LABORATORIES INC /DE income tax expense (benefit) for fiscal 2023 was $216.13M, a 19.49% increase from fiscal 2022.
- IDEXX LABORATORIES INC /DE income tax expense (benefit) for fiscal 2022 was $180.88M, a 14.62% increase from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $78.81M 10-Q · filed 2026-08-04 | $155.81M 10-Q · filed 2026-08-04 | $214.60M derived: sum of 3 quarters · filed 2026-08-04 | $284.76M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $77.00M 10-Q · filed 2026-05-05 | $135.79M derived: sum of 2 quarters · filed 2026-05-05 | $205.95M derived: sum of 3 quarters · filed 2026-05-05 | $274.31M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $58.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $128.96M derived: sum of 2 quarters · filed 2026-02-20 | $197.32M derived: sum of 3 quarters · filed 2026-08-04 | $264.73M 10-K · filed 2026-02-20 |
| 2025-09-30 | $70.16M 10-Q · filed 2025-11-03 | $138.52M derived: sum of 2 quarters · filed 2026-08-04 | $205.93M 10-Q · filed 2025-11-03 | $246.17M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $68.36M 10-Q · filed 2026-08-04 | $135.77M 10-Q · filed 2026-08-04 | $176.01M derived: sum of 3 quarters · filed 2026-08-04 | $242.08M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $67.41M 10-Q · filed 2026-05-05 | $107.64M derived: sum of 2 quarters · filed 2026-05-05 | $173.71M derived: sum of 3 quarters · filed 2026-05-05 | $229.47M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $40.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $106.31M derived: sum of 2 quarters · filed 2026-02-20 | $162.06M derived: sum of 3 quarters · filed 2026-02-20 | $221.96M 10-K · filed 2026-02-20 |
| 2024-09-30 | $66.07M 10-Q · filed 2025-11-03 | $121.83M derived: sum of 2 quarters · filed 2025-11-03 | $181.73M 10-Q · filed 2025-11-03 | $226.87M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-06-30 | $55.76M 10-Q · filed 2025-08-04 | $115.66M 10-Q · filed 2025-08-04 | $160.81M derived: sum of 3 quarters · filed 2026-02-20 | $216.47M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-03-31 | $59.90M 10-Q · filed 2025-05-01 | $105.05M derived: sum of 2 quarters · filed 2026-02-20 | $160.71M derived: sum of 3 quarters · filed 2026-02-20 | $222.40M derived: sum of 4 quarters · filed 2026-02-20 |
| 2023-12-31 | $45.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $100.81M derived: sum of 2 quarters · filed 2026-02-20 | $162.50M derived: sum of 3 quarters · filed 2026-02-20 | $216.13M 10-K · filed 2026-02-20 |
| 2023-09-30 | $55.66M 10-Q · filed 2024-10-31 | $117.35M derived: sum of 2 quarters · filed 2024-10-31 | $170.99M 10-Q · filed 2024-10-31 | $212.00M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-06-30 | $61.69M 10-Q · filed 2024-08-06 | $115.33M 10-Q · filed 2024-08-06 | $156.34M derived: sum of 3 quarters · filed 2025-02-21 | $209.58M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-03-31 | $53.63M 10-Q · filed 2024-05-01 | $94.64M derived: sum of 2 quarters · filed 2025-02-21 | $147.89M derived: sum of 3 quarters · filed 2025-02-21 | $186.99M derived: sum of 4 quarters · filed 2025-02-21 |
| 2022-12-31 | $41.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $94.25M derived: sum of 2 quarters · filed 2025-02-21 | $133.36M derived: sum of 3 quarters · filed 2025-02-21 | $180.88M 10-K · filed 2025-02-21 |
| 2022-09-30 | $53.24M 10-Q · filed 2023-11-01 | $92.35M derived: sum of 2 quarters · filed 2023-11-01 | $139.88M 10-Q · filed 2023-11-01 | $168.99M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $39.10M 10-Q · filed 2023-08-01 | $86.63M 10-Q · filed 2023-08-01 | $115.74M derived: sum of 3 quarters · filed 2024-02-22 | $159.51M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $47.53M 10-Q · filed 2023-05-02 | $76.64M derived: sum of 2 quarters · filed 2024-02-22 | $120.41M derived: sum of 3 quarters · filed 2024-02-22 | $169.53M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $29.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $72.88M derived: sum of 2 quarters · filed 2024-02-22 | $122.01M derived: sum of 3 quarters · filed 2024-02-22 | $157.81M 10-K · filed 2024-02-22 |
| 2021-09-30 | $43.77M 10-Q · filed 2022-11-01 | $92.90M derived: sum of 2 quarters · filed 2022-11-01 | $128.70M 10-Q · filed 2022-11-01 | $131.18M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $49.13M 10-Q · filed 2022-08-02 | $84.93M 10-Q · filed 2022-08-02 | $87.40M derived: sum of 3 quarters · filed 2023-02-16 | $105.04M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $35.80M 10-Q · filed 2022-05-04 | $38.28M derived: sum of 2 quarters · filed 2023-02-16 | $55.91M derived: sum of 3 quarters · filed 2023-02-16 | $90.74M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $20.11M derived: sum of 2 quarters · filed 2023-02-16 | $54.94M derived: sum of 3 quarters · filed 2023-02-16 | $79.85M 10-K · filed 2023-02-16 |
| 2020-09-30 | $17.63M 10-Q · filed 2021-11-02 | $52.46M derived: sum of 2 quarters · filed 2021-11-02 | $77.38M 10-Q · filed 2021-11-02 | $95.34M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $34.83M 10-Q · filed 2021-07-30 | $59.74M 10-Q · filed 2021-07-30 | $77.70M derived: sum of 3 quarters · filed 2022-02-16 | $101.67M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $24.92M 10-Q · filed 2021-05-04 | $42.88M derived: sum of 2 quarters · filed 2022-02-16 | $66.84M derived: sum of 3 quarters · filed 2022-02-16 | $97.26M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $17.96M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $41.92M derived: sum of 2 quarters · filed 2022-02-16 | $72.34M derived: sum of 3 quarters · filed 2022-02-16 | $94.43M 10-K · filed 2022-02-16 |
| 2019-09-30 | $23.96M 10-Q · filed 2020-10-29 | $54.38M derived: sum of 2 quarters · filed 2020-10-29 | $76.46M 10-Q · filed 2020-10-29 | $97.83M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | $30.42M 10-Q · filed 2020-07-31 | $52.50M 10-Q · filed 2020-07-31 | $73.87M derived: sum of 3 quarters · filed 2021-02-12 | $89.70M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | $22.08M 10-Q · filed 2020-04-30 | $43.45M derived: sum of 2 quarters · filed 2021-02-12 | $59.28M derived: sum of 3 quarters · filed 2021-02-12 | $87.91M derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | $21.37M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $37.19M derived: sum of 2 quarters · filed 2021-02-12 | $65.82M derived: sum of 3 quarters · filed 2021-02-12 | $80.69M 10-K · filed 2021-02-12 |
| 2018-09-30 | $15.82M 10-Q · filed 2019-10-31 | $44.45M derived: sum of 2 quarters · filed 2019-10-31 | $59.33M 10-Q · filed 2019-10-31 | $110.72M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-06-30 | $28.63M 10-Q · filed 2019-08-01 | $43.50M 10-Q · filed 2019-08-01 | $94.90M derived: sum of 3 quarters · filed 2020-02-14 | $116.43M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-03-31 | $14.87M 10-Q · filed 2019-05-01 | $66.27M derived: sum of 2 quarters · filed 2020-02-14 | $87.80M derived: sum of 3 quarters · filed 2020-02-14 | $116.98M derived: sum of 4 quarters · filed 2020-02-14 |
| 2017-12-31 | $51.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $72.93M derived: sum of 2 quarters · filed 2020-02-14 | $102.11M derived: sum of 3 quarters · filed 2020-02-14 | $117.79M 10-K · filed 2020-02-14 |
| 2017-09-30 | $21.54M 10-Q · filed 2018-11-01 | $50.71M derived: sum of 2 quarters · filed 2018-11-01 | $66.39M 10-Q · filed 2018-11-01 | $91.15M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | $29.18M 10-Q · filed 2018-08-01 | $44.86M 10-Q · filed 2018-08-01 | $69.61M derived: sum of 3 quarters · filed 2019-02-15 | $94.69M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-03-31 | $15.68M 10-Q · filed 2018-05-04 | $40.44M derived: sum of 2 quarters · filed 2019-02-15 | $65.51M derived: sum of 3 quarters · filed 2019-02-15 | $95.19M derived: sum of 4 quarters · filed 2019-02-15 |
| 2016-12-31 | $24.76M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $49.83M derived: sum of 2 quarters · filed 2019-02-15 | $79.51M derived: sum of 3 quarters · filed 2019-02-15 | $99.79M 10-K · filed 2019-02-15 |
| 2016-09-30 | $25.07M 10-Q · filed 2017-10-31 | $54.75M derived: sum of 2 quarters · filed 2017-10-31 | $75.04M 10-Q · filed 2017-10-31 | $90.43M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $29.68M 10-Q · filed 2017-08-01 | $49.96M 10-Q · filed 2017-08-01 | $65.36M derived: sum of 3 quarters · filed 2018-02-16 | $85.96M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $20.28M 10-Q · filed 2017-04-28 | $35.68M derived: sum of 2 quarters · filed 2018-02-16 | $56.28M derived: sum of 3 quarters · filed 2018-02-16 | $80.94M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $15.39M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $35.99M derived: sum of 2 quarters · filed 2018-02-16 | $60.66M derived: sum of 3 quarters · filed 2018-02-16 | $81.01M 10-K · filed 2018-02-16 |
| 2015-09-30 | $20.60M 10-Q · filed 2016-11-01 | $45.27M derived: sum of 2 quarters · filed 2016-11-01 | $65.61M 10-Q · filed 2016-11-01 | $69.52M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $24.66M 10-Q · filed 2016-08-02 | $45.01M 10-Q · filed 2016-08-02 | $48.92M derived: sum of 3 quarters · filed 2017-02-17 | $64.97M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $20.35M 10-Q · filed 2016-04-29 | $24.26M derived: sum of 2 quarters · filed 2017-02-17 | $40.30M derived: sum of 3 quarters · filed 2017-02-17 | $63.80M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $3.91M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $19.96M derived: sum of 2 quarters · filed 2017-02-17 | $43.45M derived: sum of 3 quarters · filed 2017-02-17 | $64.60M 10-K · filed 2017-02-17 |
| 2014-09-30 | $16.05M 10-Q · filed 2015-10-28 | $39.54M derived: sum of 2 quarters · filed 2015-10-28 | $60.69M 10-Q · filed 2015-10-28 | $77.42M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-06-30 | $23.50M 10-Q · filed 2015-07-30 | $44.65M 10-Q · filed 2015-07-30 | $61.37M derived: sum of 3 quarters · filed 2016-02-17 | $80.16M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-03-31 | $21.15M 10-Q · filed 2015-04-28 | $37.87M derived: sum of 2 quarters · filed 2016-02-17 | $56.66M derived: sum of 3 quarters · filed 2016-02-17 | $80.69M derived: sum of 4 quarters · filed 2016-02-17 |
| 2013-12-31 | $16.72M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-17 | $35.51M derived: sum of 2 quarters · filed 2016-02-17 | $59.54M derived: sum of 3 quarters · filed 2016-02-17 | $75.47M 10-K · filed 2016-02-17 |
| 2013-09-30 | $18.79M 10-Q · filed 2014-10-24 | $42.81M derived: sum of 2 quarters · filed 2014-10-24 | $58.74M 10-Q · filed 2014-10-24 | $78.47M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-30 | $24.03M 10-Q · filed 2014-07-25 | $39.96M 10-Q · filed 2014-07-25 | $59.68M derived: sum of 3 quarters · filed 2015-02-17 | $79.32M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-31 | $15.93M 10-Q · filed 2014-04-25 | $35.65M derived: sum of 2 quarters · filed 2015-02-17 | $55.29M derived: sum of 3 quarters · filed 2015-02-17 | $79.34M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | $19.72M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $39.36M derived: sum of 2 quarters · filed 2015-02-17 | $63.41M derived: sum of 3 quarters · filed 2015-02-17 | $82.33M 10-K · filed 2015-02-17 |
| 2012-09-30 | $19.64M 10-Q · filed 2013-10-22 | $43.69M derived: sum of 2 quarters · filed 2013-10-22 | $62.61M 10-Q · filed 2013-10-22 | $79.30M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-06-30 | $24.05M 10-Q · filed 2013-07-23 | $42.97M 10-Q · filed 2013-07-23 | $59.66M derived: sum of 3 quarters · filed 2014-02-18 | $76.79M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-03-31 | $18.92M 10-Q · filed 2013-04-23 | $35.61M derived: sum of 2 quarters · filed 2014-02-18 | $52.74M derived: sum of 3 quarters · filed 2014-02-18 | $75.02M derived: sum of 4 quarters · filed 2014-02-18 |
| 2011-12-31 | $16.70M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | $33.82M derived: sum of 2 quarters · filed 2014-02-18 | $56.10M derived: sum of 3 quarters · filed 2014-02-18 | $72.67M 10-K · filed 2014-02-18 |
| 2011-09-30 | $17.12M 10-Q · filed 2012-10-19 | $39.40M derived: sum of 2 quarters · filed 2012-10-19 | $55.97M 10-Q · filed 2012-10-19 | $70.06M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-06-30 | $22.28M 10-Q · filed 2012-07-20 | $38.85M 10-Q · filed 2012-07-20 | $52.93M derived: sum of 3 quarters · filed 2013-02-19 | $67.48M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-03-31 | $16.57M 10-Q · filed 2012-04-20 | $30.65M derived: sum of 2 quarters · filed 2013-02-19 | $45.20M derived: sum of 3 quarters · filed 2013-02-19 | $62.29M derived: sum of 4 quarters · filed 2013-02-19 |
| 2010-12-31 | $14.09M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $28.63M derived: sum of 2 quarters · filed 2013-02-19 | $45.72M derived: sum of 3 quarters · filed 2013-02-19 | $60.81M 10-K · filed 2013-02-19 |
| 2010-09-30 | $14.55M 10-Q · filed 2011-10-21 | $31.64M derived: sum of 2 quarters · filed 2011-10-21 | $46.72M 10-Q · filed 2011-10-21 | $59.67M derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-06-30 | $17.09M 10-Q · filed 2011-07-22 | $32.17M 10-Q · filed 2011-07-22 | $45.12M derived: sum of 3 quarters · filed 2012-02-17 | $57.40M derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-03-31 | $15.09M 10-Q · filed 2011-04-21 | $28.03M derived: sum of 2 quarters · filed 2012-02-17 | $40.31M derived: sum of 3 quarters · filed 2012-02-17 | $55.42M derived: sum of 4 quarters · filed 2012-02-17 |
| 2009-12-31 | $12.94M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $25.22M derived: sum of 2 quarters · filed 2012-02-17 | $40.33M derived: sum of 3 quarters · filed 2012-02-17 | $52.30M 10-K · filed 2012-02-17 |
| 2009-09-30 | $12.28M 10-Q · filed 2010-10-22 | $27.39M derived: sum of 2 quarters · filed 2010-10-22 | $39.36M 10-Q · filed 2010-10-22 | |
| 2009-06-30 | $15.11M 10-Q · filed 2010-07-23 | $27.08M 10-Q · filed 2010-07-23 | ||
| 2008-12-31 | $54.02M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |